Nordhealth AS (NORDH.OL) Stock Analysis & AI Equity Report
Nordhealth AS (NORDH.OL) overview
Nordhealth AS (NORDH.OL) stock analysis and AI equity research. For the latest completed financial year, 2025, Nordhealth AS reported revenue of EUR 50.3m and operating profit of EUR -12.6m; the year-end share price was 37.00 NOK and market capitalisation was NOK 2,967m. Nordhealth AS is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Nordhealth AS's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-05-11. Data will be refreshed during report generation.
About Nordhealth AS
Nordhealth is a healthcare software company that develops and acquires cloud-based practice management products for veterinary and therapy providers. Its core offerings include Provet and Therapy Unified Platform, which support scheduling, booking, invoicing, patient communication, and workflow management. The company also provides related APIs and integrations for clinics and hospitals across multiple markets.
Generate the Nordhealth AS report
Nordhealth AS is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Nordhealth AS and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.